New pill could stop prediabetes becoming diabetes

NCT ID NCT07286747

Recruiting now Prevention Sponsor: University Hospital Schleswig-Holstein Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Jun 12, 2026 · Updated 23 times

Summary

This study tests a new pill (CIR-NA) that releases nicotinic acid in the gut to see if it can stop prediabetes from turning into type 2 diabetes. About 390 adults with prediabetes will take the pill or a placebo daily for 26 weeks, along with lifestyle advice. The goal is to see if more people return to normal blood sugar levels with the pill.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES (INSULIN RESISTANCE, IMPAIRED GLUCOSE TOLERANCE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Medical Center Schleswig-Holstein, Campus Kiel
RECRUITING

Kiel, 24105, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Leipzig Medical Center
RECRUITING

Leipzig, 04103, Germany

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PREDIABETES (INSULIN RESISTANCE, IMPAIRED GLUCOSE TOLERANCE) PREDIABETES (INSULIN RESISTANCE, IMPAIRED GLUCOSE TOLERANCE)